Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam for Stem Cell Mobilization in AHSCT
NCT02003625Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2013
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meloxicam in Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), multiple myeloma (MM), sponsored by Massachusetts General Hospital. Started Oct 2013; status: completed.
02
Drugs
meloxicam
03
Conditions
Non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02003625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003625.